Hernández-Mesa M, Le Bizec B, Dervilly G
LABERCA, Oniris, INRAE, Nantes, 44307, France.
LABERCA, Oniris, INRAE, Nantes, 44307, France.
Anal Chim Acta. 2021 Apr 15;1154:338298. doi: 10.1016/j.aca.2021.338298. Epub 2021 Feb 17.
Exposure to chemical hazards is a growing concern in today's society, and it is of utmost interest to know the levels of exposure to chemicals and the risks associated with such exposure in order to implement effective health prevention strategies. Chemical risk analysis represents a complex and laborious task due to the large number of known substances, but also unknown compounds and emerging risks that must be addressed. In this challenging scenario, the study of metabolic perturbations induced by exposure to a given chemical hazard has recently emerged as an interesting alternative approach to apply in chemical risk analysis. Specifically, the biomarkers of effect identified by metabolomics are expected to reveal the adverse effects of chemicals and further link exposure to disease development. In this context, analytical chemistry has become an essential part of the strategy to highlight such biomarkers. The corollary is that the relevance of the discovered biomarkers will largely depend on both the quality of the analytical approaches implemented and the part of the metabolome covered by the analytical technique used. This review focuses on describing significant applications of metabolomics in the field of chemical risk analysis. The different risk assessment steps, including hazard identification, dose-response assessment and exposure assessment, and risk management are addressed through various examples to illustrate that such an approach is fit-for-purpose and meets the expectations and requirements of chemical risk analysis. It can be considered as an innovative tool for predicting the probable occurrence and nature of risks, while addressing the current challenges of chemical risk analysis (e.g. replacement, reduction and refinement (3R) of animal testing, effects of exposure to chemical mixtures at low doses, etc.), and with the aim of responding to chemical exposures concerns in a holistic manner and anticipating human health problems.
在当今社会,接触化学危害正日益受到关注,了解化学物质的接触水平以及与此类接触相关的风险对于实施有效的健康预防策略至关重要。由于已知物质数量众多,同时还存在未知化合物和新出现的风险需要应对,化学风险分析是一项复杂而艰巨的任务。在这种具有挑战性的情况下,研究接触特定化学危害所引起的代谢紊乱最近已成为化学风险分析中一种有趣的替代方法。具体而言,代谢组学确定的效应生物标志物有望揭示化学物质的不良影响,并进一步将接触与疾病发展联系起来。在此背景下,分析化学已成为突出此类生物标志物策略的重要组成部分。必然的结果是,所发现生物标志物的相关性在很大程度上既取决于所实施分析方法的质量,也取决于所用分析技术所覆盖的代谢组部分。本综述重点描述代谢组学在化学风险分析领域的重要应用。通过各种实例探讨了不同的风险评估步骤,包括危害识别、剂量反应评估和接触评估以及风险管理,以说明这种方法是适用的,并且满足化学风险分析的期望和要求。它可被视为一种创新工具,用于预测风险的可能发生情况和性质,同时应对化学风险分析当前面临的挑战(例如动物试验的替代、减少和优化(3R)、低剂量化学混合物接触的影响等),旨在全面应对化学接触问题并预测人类健康问题。